KENISHA DANIELS: Open Payments
NPI 1497220743 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 22 payments from 6 companies in 2025. Trend: 2023 $725 · 2024 $547 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $290 |
| Boston Scientific Corporation | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: DIAMONDBACK PERIPHERAL, ESPRIT, WATCHMAN FLX, LEQVIO, SAPIEN 3 Ultra RESILIA, JETSTREAM SC, Wegovy, LOKELMA.
Industry payments across IL — which companies pay providers there.
